Benefits of a comprehensive care model in patients with heart failure and anemia: UMIPIC program.

OBJECTIVES

To evaluate the prognostic benefit of the UMIPIC care program in patients with heart failure (HF) and anemia.

METHODS

Data from 3,152 patients with HF and anemia from the RICA registry were analyzed. They were divided into two groups and selected by matched match: one receiving UMIPIC follow-up (UMIPIC group, N: 621) and the other receiving conventional care (non-UMIPIC group, N: 524). Admissions and mortality were assessed during 12 months of follow-up.

RESULTS

The UMIPIC group had a lower rate of admissions for HF (19.3% vs. 29.8%; p < 0.001) and a reduction in overall mortality (24.8% vs. 36.6%; p < 0.001). Patients in the UMIPIC group with associated iron deficiency (ID) also had a lower rate of admissions for HF (19.1% vs. 32.5%; p < 0.001).

CONCLUSIONS

Implementation of the UMIPIC program in patients with HF and anemia reduces admissions and overall mortality at one year. Additional studies are needed to explore the impact of specific ID treatment within these care program.